Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 647.4211 ↑ 0.75%
[as on 11 August, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option and its peers as on 11 August, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 13.68% 0.75% 0.71% 2.48% 7.14% 14.58% 19.2% 14.32% 23.5% 16.31%
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -3.28% -0.45% -0.51% 2.47% 2.69% -2.31% 8.43% 14.72% 16.9% 14.39%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -1.04% -0.33% -0.4% 2.06% 5.62% 5.03% 11.3% 10.42% 13.93% 12.35%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 25.53% 0.63% 1.77% 5.43% 14.03% 24.83% 25.04% 19.08% 26.46% 15.23%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 3.5% -0.57% -0.64% -0.24% 0.95% 7.35% 16.35% 18.5% 20.19% 15.73%
SBI PSU Fund - DIRECT PLAN - GROWTH 1.94% -0.01% 0.12% -0.23% -1.54% 11.34% 24.56% 24.84% 21.18% 14.93%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns -9.42% 8.09% 4.71% 2.97% 68.53% 23.84% -9.16% 41.33% 35.46% -2.94%

Discrete returns (monthly)

MonthOct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026
Returns 2.24% 0.9% -1.24% -4.66% 5.31% -4.85% 6.03% 2.37% 5.46% 2.71%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 14.73% 6.43%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
99.45% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 0.55%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology13.92%
Lupin LimitedLUPIN (INE326A01037)Pharmaceuticals & Biotechnology8.45%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology6.41%
Dr. Reddy's Laboratories LimitedDRREDDY (INE089A01031)Pharmaceuticals & Biotechnology5.96%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology5.42%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services5.15%
MedPlus Health Services LimitedMEDPLUS (INE804L01022)Retailing3.86%
Ajanta Pharma LimitedAJANTPHARM (INE031B01049)Pharmaceuticals & Biotechnology3.36%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services3.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services3.15%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology3.15%
Mankind Pharma LimitedMANKIND (INE634S01028)Pharmaceuticals & Biotechnology2.87%
Aurobindo Pharma LimitedAUROPHARMA (INE406A01037)Pharmaceuticals & Biotechnology2.81%
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology2.77%
GlaxoSmithKline Pharmaceuticals LimitedGLAXO (INE159A01016)Pharmaceuticals & Biotechnology2.64%
Abbott India LimitedABBOTINDIA (INE358A01014)Pharmaceuticals & Biotechnology2.43%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology2.17%
JB Chemicals & Pharmaceuticals LimitedJBCHEPHARM (INE572A01036)Pharmaceuticals & Biotechnology2.09%
Dr. Lal Path Labs LimitedLALPATHLAB (INE600L01024)Healthcare Services2.02%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services1.94%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology1.90%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology1.72%
Narayana Hrudayalaya LimitedNH (INE410P01011)Healthcare Services1.67%
Emcure Pharmaceuticals LimitedEMCURE (INE168P01015)Pharmaceuticals & Biotechnology1.51%
Sanofi Consumer Healthcare India LimitedSANOFICONR (INE0UOS01011)Pharmaceuticals & Biotechnology1.16%
Suraksha Diagnostic LimitedSURAKSHA (INE877V01027)Healthcare Services1.12%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services1.11%
Sanofi India LimitedSANOFI (INE058A01010)Pharmaceuticals & Biotechnology0.94%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services0.93%
Akums Drugs and Pharmaceuticals LimitedAKUMS (INE09XN01023)Pharmaceuticals & Biotechnology0.89%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology0.88%
Biocon LimitedBIOCON (INE376G01013)Pharmaceuticals & Biotechnology0.67%
AstraZeneca Pharma India LimitedASTRAZEN (INE203A01020)Pharmaceuticals & Biotechnology0.62%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology0.38%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology0.14%
Portfolio data is as on date 31 March, 2026

NAV history

Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option - 30 days NAV (Net asset value) history

DateNAV% change
11 August, 2026647.4211 0.75%
10 August, 2026642.5969 0.1%
7 August, 2026641.9838 -0.01%
6 August, 2026642.0732 0.08%
5 August, 2026641.5674 -0.2%
4 August, 2026642.8853 -0.13%
3 August, 2026643.7372 0.52%
31 July, 2026640.3925 -0.19%
30 July, 2026641.6283 -0.07%
29 July, 2026642.0993 1.2%
28 July, 2026634.5023 0.12%
27 July, 2026633.7712 1.4%
24 July, 2026625.0129 -0.22%
23 July, 2026626.3854 -0.39%
22 July, 2026628.8418 -1.62%
21 July, 2026639.2095 0.34%
20 July, 2026637.0191 1.06%
17 July, 2026630.3621 -1.13%
16 July, 2026637.5345 0.23%
15 July, 2026636.0700 0.26%
14 July, 2026634.4082 0.64%
13 July, 2026630.3743 -0.22%
10 July, 2026631.7604 0.34%
9 July, 2026629.5922 0.88%
8 July, 2026624.0711 -1.13%
7 July, 2026631.1734 -0.53%
6 July, 2026634.5567 0.12%
3 July, 2026633.8175 1.21%
2 July, 2026626.2581 0.45%
1 July, 2026623.4794

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The latest NAV of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option is 647.4211 as on 11 August, 2026.
  • What are YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The YTD (year to date) returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 13.68% as on 11 August, 2026.
  • What are 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 1 year returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.58% as on 11 August, 2026.
  • What are 3 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 3 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 19.2% as on 11 August, 2026.
  • What are 5 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 5 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.32% as on 11 August, 2026.
  • What are 10 year CAGR returns of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option?
    The 10 year annualized returns (CAGR) of Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option are 14.32% as on 11 August, 2026.